<DOC>
	<DOCNO>NCT01025921</DOCNO>
	<brief_summary>We aim study whether use inhale antibiotic may impact incidence tracheobronchitis pneumonia associate use mechanical ventilation . The investigator hypothesize could possible decrease population gram negative germ colonize lumen tracheal tube upper airway .</brief_summary>
	<brief_title>Tracheobronchitis Prevention Trial</brief_title>
	<detailed_description>INTRODUCTION Gram-negative bacteria recently become endemic many ICUs around world . Ventilator associate pneumonia ( VAP ) relatively common parenteral treatment often lead low sub-therapeutic concentration antibiotic lung . Ventilator associate tracheobronchitis ( VAT ) characterize fever , purulent sputum , positive culture tracheal aspirate secretion absence new pulmonary infiltrates CXR . This entity particular interest intermediate step pathogenesis VAP ( colonization VAP ) prolong mechanical ventilatory support . Inhaled antibiotic achieve high ( peak trough ) concentration respiratory secretion . Endobronchial antibiotic give non-cystic fibrosis patient prevention VAP . Colistimethate sodium ( colistin ) give instillation decrease incidence Gram-negative pneumonia lead development colistin resistant bacteria . AIM The study prospective open label randomize study aim clarify effect colistin : 1 . The incidence VAP The incidence VAT 2 . Mechanical ventilation free day 3 . Incidence multidrug resistant bacteria tracheal aspirate culture METHODS Settings : The study perform ICU University Larissa ( 12 bed ) . Entry criterion : All intubate tracheostomised patient , old 18 year old duration intubation 48 hour . Exclusion criterion : 1 ) Purulent sputum within 48 hour admission . 2 ) Pneumonia within 48 hour intubation 3 ) New chest X ray infiltrate , 4 ) Advanced COPD lead intubation 5 ) Pregnancy 6 ) Allergy colistin 7 ) Resistance bacterial strain colistin . Tools : Randomization patient two group : first group receive nebulized colistin treatment . The initial dose 1000000 unit double measurement drug concentration tracheal secretion . The drug start admission stop 10 day . All patient give respiratory bundle measure ( semi-recumbent position , daily interruption sedation ) part usual daily practice ICU except otherwise indicate . The severity patient estimate APACHE II score admission SOFA score thrice weekly . CPIS score screen tool pneumonia estimate well thrice weekly . Tracheal aspirate culture admission thrice weekly thereafter first two week twice weekly thereafter . The patient follow thirty day measure outcome .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>All intubate tracheostomized patient , old 18 year old duration intubation 48 hour . Purulent sputum within 48 hour admission Pneumonia within 48 hour intubation New chest X ray infiltrate Advanced COPD lead intubation Pregnancy Allergy colistin Resistance bacterial strain colistin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Tracheobronchitis</keyword>
	<keyword>pneumonia</keyword>
	<keyword>inhale antibiotic</keyword>
	<keyword>colistin</keyword>
	<keyword>Ventilator associate tracheobronchitis</keyword>
	<keyword>Ventilator associate pneumonia</keyword>
</DOC>